| Everolimus |
依维莫司 |
159351-69-6 |
| Benzaldehyde, 4-methoxy-3-(3-methoxypropoxy)- |
3-(3-甲氧基丙氧基)-4-甲氧基苯甲醛 |
172900-75-3 |
| 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione |
5-(2-甲氧基苯氧基)-[2,2'-二嘧啶]-4,6(1H,5H)-二酮 |
150728-12-4 |
| BNP-32 (RAT) |
脑利钠肽 |
133448-20-1 |
| 1-(4-BROMOPHENYL)CYCLOPROPANECARBONITRILE, 97 |
1-(4-溴苯基)环丙烷甲腈 |
124276-67-1 |
| 3-CHLORO-5-(CHLOROMETHYL)PYRIDINE |
3 - 氯-5 - 氯甲基吡啶 |
847737-51-3 |
| 3-ethynyl-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
3-乙炔基-4-甲基-N-(4-((4-甲基哌嗪-1-基)甲基)-3-(三氟甲基)苯基)苯甲酰胺 |
957147-18-1 |
| Tadalafil iMpurity D |
他达拉非杂质D |
951661-81-7 |
| (R)-methyl 4-((3R,5S,6R,7R,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate |
奥贝胆酸杂质48 |
951694-73-8 |
| tert-Butyl 4-(1H-indol-3-yl)piperazine-1-carboxylate |
4-(1H-吲哚-3-基)哌嗪-1-甲酸叔丁酯 |
947498-87-5 |
| Ethyl trans-2-[4-(Boc-aMino)cyclohexyl]acetate |
反式-2-[4-(BOC-氨基)环己基]乙酸乙酯 |
946598-34-1 |
| 2-(2-FLUOROPHENYL)-N-METHOXY-N-METHYLACETAMIDE |
2-(2-氟苯基)-N-甲氧基-N-甲基乙酰胺 |
946402-23-9 |
| Axitinib Impurity B |
阿昔替尼杂质B |
944835-85-2 |
| 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
鲁索利替尼中间体 |
941688-05-7 |
| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| Dabigatran iMpurity O |
达比加群杂质O |
948551-71-1 |
| (E)-2-chloro-5-(4-nitrostyryl)pyridine |
(E)-2-chloro-5-(4-nitrostyryl)pyridine |
938435-66-6 |
| Lumacaftor Intermediate |
鲁玛卡托中间体 |
936727-68-3 |
| Lumacaftor (VX-809) |
鲁玛卡托 |
936727-05-8 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
QQ
微信
